Screener
Core Laboratories CLB Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.
The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-198109
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Income taxes payable | 4,214 | 4,255 |
| Other current liabilities | 17,373 | 16,680 |
| TOTAL CURRENT LIABILITIES | 104,734 | 106,015 |
| LONG-TERM DEBT, net | 114,460 | 110,255 |
| LONG-TERM OPERATING LEASE LIABILITIES | 41,285 | 42,309 |
| DEFERRED COMPENSATION | 28,165 | 29,381 |
| DEFERRED TAX LIABILITIES, net | 8,073 | 7,995 |
| OTHER LONG-TERM LIABILITIES | 15,867 | 15,847 |
Item 1. Financial Statements
FAQ
- What is Core Laboratories's long-term debt?
- Core Laboratories (CLB) reported long-term debt of $114.46M in Q1 2026.
- How has Core Laboratories's long-term debt changed year-over-year?
- Core Laboratories's long-term debt decreased by 8.0% year-over-year, from $124.37M to $114.46M.
- What is the long-term trend for Core Laboratories's long-term debt?
- Over 3 years (2022 to 2025), Core Laboratories's long-term debt has grown at a -13.8% compound annual growth rate (CAGR), from $172.39M to $110.26M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Core Laboratories's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude